Document is current
Any future updates will be listed below
-
Authors
Zwart, K.
Velthuis, S.
Polyukhovych, Y. V.
Mosterd, A.
Smidt, L.
Serné, E. H.
van Raalte, D. H.
Elders, P. J. M.
Handoko, M. L. https://orcid.org/0000-0002-8942-7865
Oldenburg-Ligtenberg, P. C.
- License Information
-
More Information
Article History
Accepted: 29 April 2021
First Online: 16 June 2021
Declarations
:
: K. Zwart has received a small grant for writing an AstraZeneca educational programme. S. Velthuis has received speaker’s fees from Boehringer Ingelheim and AstraZeneca. A. Mosterd has received a small grant for writing an AstraZeneca educational programme. However, he does not accept personal fees from pharmaceutical companies. Therefore, these fees will be donated to research foundations. D.H. van Raalte serves on advisory boards for Boehringer Ingelheim, Eli Lilly Alliance, Sanofi and Merck Sharp & Dohme (MSD) and has received research grants from AstraZeneca, Boehringer Ingelheim, Eli Lilly, Sanofi and MSD. All honoraria were paid to his employer. M.L. Handoko serves on advisory boards for Novartis, Boehringer Ingelheim, Vifor Pharma, AstraZeneca, Bayer, MSD and Quin. He has also received education and research grants from Novartis, Boehringer Ingelheim and Vifor Pharma, which were paid to his employer. P.C. Oldenburg-Ligtenberg has served on an advisory board for Boehringer Ingelheim. She has also received a small grant for writing an AstraZeneca educational programme and a speaker’s fee from Boehringer Ingelheim. Y.V. Polyukhovych, L. Smidt, E.H. Serné and P.J.M. Elders declare that they have no competing interests.
